FDA Inspection 1108843 — Shore Institute For Reproductive Medicine, P.C.
The FDA completed an inspection of Shore Institute For Reproductive Medicine, P.C. on Oct 24, 2019 in Lakewood, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Oct 24, 2019
- Fiscal Year
- 2020
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Lakewood, NJ (United States)